Latest Breaking News On - Su yi chang - Page 2 : comparemela.com

A Chinese medicine-based herbal formula developed in Taiwan called Taiwan Chingguan Erhau (清冠二號), or NRICM102, could reduce the mortality rate of COVID-19 cases who experience severe symptoms by 50 percent, National Research Institute of Chinese Medicine (NRICM) director Su Yi-chang (蘇奕彰) said. Su talked about the treatment on Sunday at the Taipei Traditional Chinese Medicine International Forum, saying that following the success of Taiwan Chingguan Yihau (清冠一號), or NRICM101, the institute is applying for patents and trademarks for the new formulation. In 2020, permission was granted to export Taiwan Chingguan Yihau, and it has been sold in more than 50 countries with

T ai peiChingguan yihauTsai si peiChingguan erhauSu yi changTaipei traditional chinese medicine international forumNational research institute of chinese medicineMinistry of healthTaipei timesLiu tzu hsuanTaiwan chingguan erhauNational research instituteChinese medicineTaiwan chingguan yihauResearch instituteTri service general hospital